BIODESIX, INC. (BDSX) Operating cash flow 2019–2025
BIODESIX, INC. (BDSX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$23.3MFY2025 · since FY2019: -$21.7M → -$23.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.3M | +52.2% |
| FY2024 | -$48.6M | -112.7% |
| FY2023 | -$22.9M | +49.1% |
| FY2022 | -$45.0M | -59.3% |
| FY2021 | -$28.2M | -32.1% |
| FY2020 | -$21.4M | +1.7% |
| FY2019 | -$21.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BDSX financial trends
BDSX RevenueBDSX Net incomeBDSX Net marginBDSX Gross profitBDSX Gross marginBDSX Operating incomeBDSX Operating marginBDSX Free cash flowBDSX Capital expendituresBDSX Return on equityBDSX Stock buybacksBDSX Dividends paidBDSX Total assetsBDSX Total liabilitiesBDSX Shareholders’ equityBDSX overview →